# CASE WESTERN RESERVE UNIVERSITY: Repurposing the NMDA Receptor Antagonist Memantine as a Cognitive Enhancer in Stage 0 Alzheimer's Disease in Persons with Down Syndrome

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | CASE WESTERN RESERVE UNIVERSITY |
| Location | CLEVELAND, OH |
| Project | Repurposing the NMDA Receptor Antagonist Memantine as a Cognitive Enhancer in Stage 0 Alzheimer's Disease in Persons with Down Syndrome |
| Project number | 1UG3AG101220-01 |
| Mechanism | UG3 |
| Institute | National Institute on Aging |
| Award | $496,214 |
| Awarded | 2026-09-07 |
| Project period | 2026-09-15 to 2028-08-31 |
| UEI | HJMKEF7EJW69 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11358327). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.